Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yasuhiko Yoshida is active.

Publication


Featured researches published by Yasuhiko Yoshida.


PLOS ONE | 2012

Curcumin Loaded-PLGA Nanoparticles Conjugated with Tet-1 Peptide for Potential Use in Alzheimer's Disease

Anila Mathew; Takahiro Fukuda; Yutaka Nagaoka; Takashi Hasumura; Hisao Morimoto; Yasuhiko Yoshida; Toru Maekawa; Kizhikkilot Venugopal; D. Sakthi Kumar

Alzheimers disease is a growing concern in the modern world. As the currently available medications are not very promising, there is an increased need for the fabrication of newer drugs. Curcumin is a plant derived compound which has potential activities beneficial for the treatment of Alzheimers disease. Anti-amyloid activity and anti-oxidant activity of curcumin is highly beneficial for the treatment of Alzheimers disease. The insolubility of curcumin in water restricts its use to a great extend, which can be overcome by the synthesis of curcumin nanoparticles. In our work, we have successfully synthesized water-soluble PLGA coated- curcumin nanoparticles and characterized it using different techniques. As drug targeting to diseases of cerebral origin are difficult due to the stringency of blood-brain barrier, we have coupled the nanoparticle with Tet-1 peptide, which has the affinity to neurons and possess retrograde transportation properties. Our results suggest that curcumin encapsulated-PLGA nanoparticles are able to destroy amyloid aggregates, exhibit anti-oxidative property and are non-cytotoxic. The encapsulation of the curcumin in PLGA does not destroy its inherent properties and so, the PLGA-curcumin nanoparticles can be used as a drug with multiple functions in treating Alzheimers disease proving it to be a potential therapeutic tool against this dreaded disease.


Biotechnology and Bioengineering | 2012

AS1411 aptamer tagged PLGA‐lecithin‐PEG nanoparticles for tumor cell targeting and drug delivery

Athulya Aravind; Prashanti Jeyamohan; Remya Nair; Srivani Veeranarayanan; Yutaka Nagaoka; Yasuhiko Yoshida; Toru Maekawa; D. Sakthi Kumar

Liposomes and polymers are widely used drug carriers for controlled release since they offer many advantages like increased treatment effectiveness, reduced toxicity and are of biodegradable nature. In this work, anticancer drug‐loaded PLGA‐lecithin‐PEG nanoparticles (NPs) were synthesized and were functionalized with AS1411 anti‐nucleolin aptamers for site‐specific targeting against tumor cells which over expresses nucleolin receptors. The particles were characterized by transmission electron microscope (TEM) and X‐ray photoelectron spectroscopy (XPS). The drug‐loading efficiency, encapsulation efficiency and in vitro drug release studies were conducted using UV spectroscopy. Cytotoxicity studies were carried out in two different cancer cell lines, MCF‐7 and GI‐1 cells and two different normal cells, L929 cells and HMEC cells. Confocal microscopy and flowcytometry confirmed the cellular uptake of particles and targeted drug delivery. The morphology analysis of the NPs proved that the particles were smooth and spherical in shape with a size ranging from 60 to 110 nm. Drug‐loading studies indicated that under the same drug loading, the aptamer‐targeted NPs show enhanced cancer killing effect compared to the corresponding non‐targeted NPs. In addition, the PLGA‐lecithin‐PEG NPs exhibited high encapsulation efficiency and superior sustained drug release than the drug loaded in plain PLGA NPs. The results confirmed that AS1411 aptamer‐PLGA‐lecithin‐PEG NPs are potential carrier candidates for differential targeted drug delivery. Biotechnol. Bioeng. 2012; 109: 2920–2931.


Biomedical Materials | 2012

Hybrid fluorescent curcumin loaded zein electrospun nanofibrous scaffold for biomedical applications

Dhandayuthapani Brahatheeswaran; Anila Mathew; Ravindran Girija Aswathy; Yutaka Nagaoka; Kizhikkilot Venugopal; Yasuhiko Yoshida; Toru Maekawa; D Sakthikumar

Nanomedicine utilizes engineered nanodevices and nanostructures for monitoring, repair, construction and control of human biological systems at the molecular level. In this study, we investigated the feasibility and potential of zein nanofiber as a delivery vehicle for curcumin in biomedical applications. By optimizing the electrospinning parameters, ultrafine zein fluorescence nanofibers containing curcumin were developed with interconnected fibrous networks. We found that these nanofibers show an increase in fluorescence due to the incorporation of curcumin. The morphology and material properties of the resulting multifunctional nanofiber including the surface area were examined by a field emission-scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and confocal microscopy. The surface area and pore size were characterized by N(2) adsorption-desorption isotherm. SEM and fluorescence images showed that the uniform fibers with smooth surface had an average diameter of about 310 nm. An in vitro degradation study showed significant morphological changes. The in vitro evaluations suggested that the curcumin incorporated zein nanofibers showed sustained release of curcumin and maintained its free radical scavenging ability. It provides an attractive structure for the attachment and growth of fibroblast as cell culture surfaces. The results demonstrate that the curcumin loaded zein nanofiber could be a good candidate for soft tissue engineering scaffolds and has the potential for further applications in drug delivery system.


Journal of Physics D | 2008

Microstructure and random magnetic anisotropy in Fe-Ni based nanocrystalline thin films

Senoy Thomas; Salim H. Al-Harthi; Dasappan Nair Sakthikumar; I A Al-Omari; R.V. Ramanujan; Yasuhiko Yoshida; M. R. Anantharaman

Nanocrystalline Fe–Ni thin films were prepared by partial crystallization of vapour deposited amorphous precursors. The microstructure was controlled by annealing the films at different temperatures. X-ray diffraction, transmission electron microscopy and energy dispersive x-ray spectroscopy investigations showed that the nanocrystalline phase was that of Fe–Ni. Grain growth was observed with an increase in the annealing temperature. X-ray photoelectron spectroscopy observations showed the presence of a native oxide layer on the surface of the films. Scanning tunnelling microscopy investigations support the biphasic nature of the nanocrystalline microstructure that consists of a crystalline phase along with an amorphous phase. Magnetic studies using a vibrating sample magnetometer show that coercivity has a strong dependence on grain size. This is attributed to the random magnetic anisotropy characteristic of the system. The observed coercivity dependence on the grain size is explained using a modified random anisotropy model.


Surface & Coatings Technology | 2003

Dielectric properties of plasma polymerized pyrrole thin film capacitors

D. Sakthi Kumar; Yasuhiko Yoshida

Abstract Plasma polymerized polymer film from pyrrole was produced by radio frequency plasma polymerization and their dielectric properties were studied in the frequency range from 1 kHz to 1 MHz at various temperatures from 303 to 423 K. The large increase in the capacitance towards the low frequency region indicates the possibility of an interfacial polarization mechanism prevailing in that region. The value of dielectric constant and dielectric strength of this polymer gives a remarkable importance in the field of capacitors.


Small | 2012

Synergistic Targeting of Cancer and Associated Angiogenesis Using Triple‐Targeted Dual‐Drug Silica Nanoformulations for Theragnostics

Srivani Veeranarayanan; Aby Cheruvathoor Poulose; M. Sheikh Mohamed; Saino Hanna Varghese; Yutaka Nagaoka; Yasuhiko Yoshida; Toru Maekawa; D. Sakthi Kumar

The targeting and therapeutic efficacy of dye- and dual-drug-loaded silica nanoparticles, functionalized with triple targeting ligands specific towards cancer and neoangiogenesis simultaneously, are discussed. This synergized, high-precision, multitarget concept culminates in an elevated uptake of nanoparticles by cancer and angiogenic cells with amplified proficiency, thereby imparting superior therapeutic efficacy against breast cancer cells and completely disabling the migration and angiogenic sprouting ability of activated endothelial cells. The exceptional multimodal efficiency achieved by this single therapeutic nanoformulation holds promise for the synergistic targeting and treatment of the yet elusive cancer and its related angiogenesis in a single, lethal shot.


Advances in Natural Sciences: Nanoscience and Nanotechnology | 2012

Biocompatible fluorescent zein nanoparticles for simultaneous bioimaging and drug delivery application

Ravindran Girija Aswathy; Balasubramanian Sivakumar; Dhandayudhapani Brahatheeswaran; Takahiro Fukuda; Yasuhiko Yoshida; Toru Maekawa; D. Sakthi Kumar

We report the synthesis of 5-fluorouracil (5-FU) loaded biocompatible fluorescent zein nanoparticles. Zein is the storage protein in corn kernels that has a variety of unique characteristics and functionalities that makes zein valuable in various commercial applications. It is classified as generally recognized as safe (GRAS) by the Food and Drug Administration (FDA). We synthesized zein nanoparticles of around 800nm in size and conjugated with quantum dot ZnS : Mn. The nanoparticle was in turn encapsulated with the drug 5-FU. The luminescent properties of these nanoparticles were studied by using fluorescence microscopy. The nanoparticles were characterized and the drug release profile was studied. The biocompatibility of zein nanoparticle and the cytotoxicity with drug-loaded nanoparticle was studied in L929 and MCF-7 cell lines. The nanoparticles were successfully employed for cellular imaging. In vitro drug release studies were also performed. The biocompatibility of the nanoparticle showed that nanoparticles at higher concentrations are compatible for cells and are expected to be promising agents for the targeted delivery of drugs in the near future.


Journal of Applied Physics | 2003

Optical and electrical characterization of plasma polymerized pyrrole films

D. Sakthi Kumar; Kenji Nakamura; Satoko Nishiyama; Shigeru Ishii; Hiromichi Noguchi; Kunihiro Kashiwagi; Yasuhiko Yoshida

Plasma polymerization of pyrrole was carried out in the presence and absence of iodine, and the resulting films were characterized by optical and electrical means. Their infrared spectra were very similar to each other, suggesting that iodine was neither bonded in any manner to, nor strongly interacting with, the pyrrole polymer chains. Based on their infrared spectra, a chemical structure was proposed for the plasma-polymerized pyrrole (PPPy) film. An analysis of the electronic spectra gave band gap energies of 1.3 and 0.8 eV for the undoped and doped PPPy films, respectively. In line with this result, the current–voltage characteristics of the two types of polymer films revealed that the conductivity of the doped PPPy film was approximately two times greater than that of the undoped one. An investigation of the scanning electron micrographs led us to conclude that iodine had changed the surface morphology of the PPPy film, resulting in the small increase in conductivity. A detailed analysis of the condu...


RSC Advances | 2013

Aptamer conjugated theragnostic multifunctional magnetic nanoparticles as a nanoplatform for pancreatic cancer therapy

Balasubramanian Sivakumar; Ravindran Girija Aswathy; Yutaka Nagaoka; Seiki Iwai; Kizhikkilot Venugopal; Kazunori Kato; Yasuhiko Yoshida; Toru Maekawa; Dasappan Nair Sakthi Kumar

Pancreatic cancer is the fifth leading cause of cancer related deaths worldwide. Currently, finding an effective drug delivery strategy in pancreatic cancer treatment is a major challenge. Nanotechnology offers an indispensible function by precisely delivering anticancer therapeutics in a targeted method to the cancer specific cells thus sparing normal healthy cells and hence resulting in an enhanced efficiency. The development of designer multifunctional therapeutics with magnetic nanoparticles (MNP) is a promising approach to selectively deliver therapeutics and image them in cancer cells. This study explored the preparation, characterization and application of a targeted nanosystem represented by an aptamer conjugated dual drug (curcumin and gemcitabine-loaded) and MNP encapsulated PLGA nanoparticles (Apt-Cur-Gem-PLGA-MNPs) for pancreatic cancer therapy. The aptamer targeted NPs exhibited excellent antiproliferative activity leading to apoptosis owing to enhanced cellular uptake. The presence of MNP in the nanoconjugate was exploited for magnetic hyperthermia and magnetic ablation of cancer cells by a rotating magnetic field. Thus, Apt-Cur-Gem-PLGA-MNPs is able to deliver an effective and targeted delivery of therapeutics for pancreatic cancer treatment.


Cancer Nanotechnology | 2012

Aptamer-labeled PLGA nanoparticles for targeting cancer cells

Athulya Aravind; Saino Hanna Varghese; Srivani Veeranarayanan; Anila Mathew; Yutaka Nagaoka; Seiki Iwai; Takahiro Fukuda; Takashi Hasumura; Yasuhiko Yoshida; Toru Maekawa; D. Sakthi Kumar

Cancer is one of the leading causes of death in most parts of the world and is a very serious cause of concern particularly in developing countries. In this work, we prepared and evaluated the aptamer-labeled paclitaxel-loaded poly(lactic-co-glycolic acid) (PLGA) nanoparticles (Apt-PTX-PLGA NPs) which can ameliorate drug bioavailability and enable accurate drug targeting to cancer cells with controlled drug release for cancer therapy. Paclitaxel-loaded PLGA nanoparticles (PTX-PLGA NPs) were formulated by a single-emulsion/solvent evaporation method and were further surface-functionalized with a chemical cross-linker bis(sulfosuccinimidyl) suberate (BS3) to enable binding of aptamer on to the surface of the nanoparticles. The prepared nanoparticles were characterized by atomic force microscopy, scanning electron microscopy, and X-ray photoelectron spectroscopy. Cytotoxicity studies were carried out using normal human mammary epithelial cells (HMEC cells) and human glial cancer cells (GI-1 cells) by methylthiazolyldiphenyl-tetrazolium bromide assay and Alamar blue assay, which confirmed that PTX-PLGA NPs with aptamer conjugation (Apt-PTX-PLGA NPs) were comparatively non-toxic to HMEC cells while toxic to GI-1 cancer cells. Cellular uptake of PTX-PLGA NPs with and without aptamer conjugation was studied using GI-1 cells and monitored by confocal microscopy and phase contrast microscopy. Our studies demonstrated significant internalization and retention of nanoparticles inside the cells, inducing apoptosis. The preferential accumulation of PTX-PLGA NPs within the cancer cells were also confirmed by flow cytometry-based uptake studies. The results indicated that Apt-PTX-PLGA NPs could be a promising targeted therapeutic delivery vehicle for cancer treatment.

Collaboration


Dive into the Yasuhiko Yoshida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge